From raw reads to evidence-backed research findings.
Automated variant interpretation at scale, VUS reduction, and evidence linking — built to support a research study end to end.
Interpretation and evidence, at cohort scale
Move from thousands of variants to a focused, evidence-linked shortlist you can take into a study.
- Deep multi-omics annotation and pathogenicity prediction.
- AI structural and functional predictions via NVIDIA BioNeMo (Evo2, ESM2, and more).
- Literature-grounded evidence with citations (VMIS + BioBERT / PubMed).
- Programmatic API access for cohort- and scale-level analysis.
- VUS reduction and phenotype-driven gene prioritization to focus a study — validated on synthetic clinical notes; real-world EHR validation in progress.
- Evidence and mechanism linking to support a research hypothesis.
The machinery behind the evidence
Foundation models, grounded literature, and programmatic access — presented under a single validation-in-progress umbrella.
Foundation models
NVIDIA BioNeMo foundation models integrated for structural and functional prediction — validation in progress.
Grounded evidence
Findings linked to the published literature through VMIS, BioBERT, and PubMed for traceable review.
Programmatic access
An API for cohort- and scale-level analysis, so interpretation fits into your existing research pipeline.
Research Use Only
GeneGenius is for research use only (RUO) and is not intended for use in diagnostic procedures or clinical decision-making. Analytical capabilities are under ongoing validation.
See GeneGenius on your own data.
From a raw VCF or FASTQ to an interpretable, evidence-linked research report — in minutes.
Explore other services